Literature DB >> 2447675

Closure of the pericardium using expanded polytetrafluoroethylene GORE-TEX-Surgical Membrane: clinical experience.

C Minale1, G Hollweg, S Nikol, C Mittermayer, B J Messmer.   

Abstract

Complete closure of the pericardium after cardiac operation would have the advantage of avoiding injury of the heart and great vessels should repeat sternotomy prove to be necessary. In such situations, various pericardial closure techniques have been described. Synthetic materials produced severe scarring, while xenografts appeared to be satisfactory, although fibrous reactions and aseptic cystic formations have been reported recently. Between 1985 and 1986 we closed the pericardium with GORE-TEX-Surgical Membrane in a selected series of 72 patients aging 1 month to 76 years, median 24 years. Overall hospital mortality was 3/72 cases. In no instance was there a relationship between death occurrence and pericardial closure through Surgical Membrane. There were 5 cases each of low cardiac output and rethoracotomy because of bleeding. No cardiac tamponade occurred. Two patients had to be reoperated three and four weeks after primary repair. Surgical Membrane was explanted. Electron microscopy examination showed no cellular ingrowth in the low porosity membrane. No immunocompetent cellular compounds were present on either side of the graft. Follow-up interval averaged 13 months. No complication related to pericardial closure has occurred until now. The Surgical Membrane has the advantages of easy availability, of lack of reactions both between its surface and the underlying epicardium and with the rest of the pericardium. We believe its routine use should be encouraged mainly in patients with high probability of reoperation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447675     DOI: 10.1055/s-2007-1020253

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

Review 1.  Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.

Authors:  Laura Iop; Tiziana Palmosi; Eleonora Dal Sasso; Gino Gerosa
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Use of polytetrafluoroethylene surgical membrane as a pericardial substitute in the correction of congenital heart defects.

Authors:  M Loebe; V Alexi-Meskhishvili; Y Weng; G Hausdorf; R Hetzer
Journal:  Tex Heart Inst J       Date:  1993

3.  A modified rabbit ulna defect model for evaluating periosteal substitutes in bone engineering: a pilot study.

Authors:  Rania M El Backly; Danilo Chiapale; Anita Muraglia; Giuliana Tromba; Chiara Ottonello; Federico Santolini; Ranieri Cancedda; Maddalena Mastrogiacomo
Journal:  Front Bioeng Biotechnol       Date:  2015-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.